Antibiotic resistance mechanisms of clinically important bacteria

Medicina

Volumn 47, Issue 3, 2011, Pages 137-146

  Giedraitiene, Agne ^a   Vitkauskiene, Astra ^a   Naginiene, Rima ^a   Pavilonis, Alvydas ^a  

^a LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

Author keywords

Antibiotics; Bacteria; Resistance mechanisms

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BACTERIUM; CELL MEMBRANE PERMEABILITY; CLASSIFICATION; DRUG EFFECT; METABOLISM; MICROBIOLOGY; REVIEW;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; CELL MEMBRANE PERMEABILITY; DRUG RESISTANCE, BACTERIAL;

EID: 80053327426     PISSN: 00257729     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Džidic S, Šuškovic J, Kos B. Antibiotic resistance mechanisms in bacteria: biochemical and genetic aspects. Food Technol Biotechnol 2008;46:11-21.
2. Vaičiuvėnas V. Antimikrobinio gydymo mikrobiologija. (Anti microbial microbiology.) In: Lasinskaitė-Čerkasina A, Pavilonis A, Vaičiuvėnas V, editors. Medicinos mikrobiologija ir virusologijos pagrindai. (Basics of medical microbiology and virology.) Kaunas: Vitae Litera; 2005. p. 287-335.
3. Rice LB, Sahm D, Binomo RA. Mechanisms of resistance to antibacterial agents. In: Murray PR, Baron EJ, Jorgensen JH, Phaller MA, Yolken RH, editors. Manual of clinical microbiology. Washington: ASM Press; 2003. p. 1074-101.
4. Martínez JL, Baquero F. Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance. Clin Microbiol Rev 2002; 15(4):647-79.
5. Alekshun MN, Levy SB. Molecular mechanisms of antibacterial multidrug resistance. Cell 2007;128:1037-50.
6. Hawkey PM. The origins and molecular basis of antibiotic resistance. BMJ 1998;317:657-60.
7. Attacking the enemy: antimicrobial agents and chemotherapy. In: Mims C, Dockrell HM, Goering RV, Roitt I, Wakelin D, Zuckerman M, editors. Medical microbiology. Elsevier Mosby; 2004. p. 473-507.
8. Raghunath D. Emerging antibiotic resistance in bacteria with special reference to India. J Biosci 2008;33(4):593-603.
9. Levy SB. The challenge of antibiotic resistance. Sci Am 1998;46-53.
10. Hooper DC. Minimizing potential resistance: the molecular view - a comment on Courvalin and Trieu-Cuot. Clin Infect Dis 2001;33(Suppl 3):S157-60.
11. Martínez JL, Baquero F. Mutation frequencies and antibiotic resistance. Antimicrob Agents Chemother 2000;44(7):1771-7.
12. Erill I, Campoy S, Mazon G, Barbé J. Dispersal and regulation of an adaptive mutagenesis cassette in the bacteria domain. Nucleic Acids Res 2006;34:66-77.
13. Guerin E, Cambray G, Sanchez-Alberola N, Campoy S, Erill I, Da Re S, et al. The SOS response controls integron recombination. Science 2009;324:1034-7.
14. Bennett PM. Plasmid encoded antibiotic resistance: acquisition and transfer of antibiotic resistance genes in bacteria. Br J Pharmacol 2008;153:347-57.
15. Hawkey P. Molecular epidemiology of clinical significant antibiotic resistance genes. Br J Pharmacol 2008;153:406-13.
16. Mayer KH, Opal SM, Medeiros AA. Mechanisms of antibiotic resistance. In: Mandell GL, Bennett JE, Dolin R, editors. Basic principles in the diagnosis and management of infectious diseases. Churchill Livingstone: An Imprint of Elsevier; 1995. p. 212-25.
17. Tolmasky ME. Bacterial resistance to aminoglycosides and beta-lactams: the Tn1331 transposon paradigm. Front Biosci 2000;5:D20-9.
18. Roe TM, Pillai SD. Monitoring and identifying antibiotic resistance mechanisms in bacteria. Poult Sci 2003;82:622-6.
19. Daikos GL, Kosmidis C, Tassios PT, Petrikkos G, Vasilakopoulou A, Psychogiou M, et al. Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome. Antimicrob Agents Chemother 2007;51(7):2366-72.
20. Wright GD. Bacterial resistance to antibiotics: enzymatic degradation and modification. Adv Drug Delivery Rev 2005;57(10):1451-70.
21. Chen CM, Huang M, Chen HF, Ke SC, Li CR, Wang JH, Wu LT. Fusidic acid resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in a Taiwanese hospital. BMC Microbiology 2011;11:98.
22. Wickens H, Wade P. Understanding antibiotic resistance. Pharm J 2005;274:501-4.
23. Jacoby GA, Munoz-Price LS. The new β-lactamases. N Engl J Med 2005;352:380-91.
24. Thomson JM, Bonomo R. The threat of antibiotic resistance in Gram-negative pathogenic bacteria: β-lactams in peril! Curr Opinion Microbiol 2005;8:518-24.
25. Bush K, Jacoby GA, Medeiros A. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995;39(8):1211-33.
26. Garau G, Garcia-Saez I, Bebrone C, Anne C, Mercuri P, Galleni M, et al. Update of the standard numbering schemefor class B β-lactamases. Antimicrob Agents Chemother 2004;48(7):2347-9.
27. Lambert PA. Mechanisms of antibiotic resistance in Pseudomonas aeruginosa. J R Soc Med 2002;95 Suppl 41:22-6.
28. Vatopoulos A. High rates of metallo-beta-lactamases-producing Klebsiella pneumoniae in Greece - a review of the current evidence. Euro Surveill 2008;13(4):1-6.
29. Babic M, Hujer AM, Bonomo RA. What's new in antibiotic resistance? Focus on beta-lactamases. J Drup 2006;9:142-56.
30. Ma L, Chang FY, Fung CP, Chen TL, Lin JC, Lu PL, et al. Variety of TEM-, SHV-, and CTX-M-type β-lactamases present in recent clinical isolates of Escherichia coli, Klebsiella pneumonia, and Enterobacter cloacae from Taiwan. Micriob Drug Resist 2005;11:1:31-9.
31. Livermore DM. β-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995;8(4):557-84.
32. Paterson DL, Bonomo RA. Extended-spectrum β-lacta mases: a clinical update. Clin Microbiol Rev 2005;18(4):657-86.
33. Livermore DM, Woodford N. The β-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol 2006;14(9):413-20.
34. Bonnet R. Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004;48(1):1-14.
35. Vitkauskienė A, Dudzevičius V, Ryškus L, Adukauskienė D, Sakalauskas R. Klebsiella pneumoniae, gaminančiu{ogonek} plataus spektro veikimo beta laktamazes, išskyrimo iš bronchu{ogonek} sekreto dažnis ir atsparumas antibiotikams. (The rate of isolation of Klebsiella pneumoniae producing extendedspectrum beta-lactamases and resistance to antibiotics.) Medicina (Kaunas) 2006;42(4):288-93.
36. Govinden U, Mocktar C, Moodley P, Sturm AW, Essack SY. Geographical evolution of the CTX-M β-lactamase: an update. Afr J Biotechnol 2007;6:831-9.
37. Kim Y-K, Cha C-J, Cerniglia CE. Purification and characterization of an erythromycin esterase from an erythromycin-resistant Pseudomonas sp. FEMS Microbiol Lett 2002; 210:239-44.
38. Strateva T, Yordanov D. Pseudomonas aeruginosa - a phenomenon of bacterial resistance. J Med Microbiol 2009;58:1133-48.
39. Maurice F, Broutin I, Podglajen I, Benas P, Collatz E, Dardel F. Enzyme structural plasticity and the emergence of broad-spectrum antibiotic resistance. EMBO Rep 2008;9(4):344-9.
40. Hartman BJ, Tomasz A. Expression of methicillin resistance in heterogeneous strains of Staphylococcus aureus. Antimicrob Agents Chemother 1986;26:85-92.
41. Hiramatsu K, Cui L, Kuroda M, Ito T. The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol 2001;9(10):486-93.
42. Lencastre H, Oliveira D, Tomasz A. Antibiotic resistant Staphylococcus aureus: a paradigm of adaptive power. Curr Opin Microbiol 2007;10:428-35.
43. Grudmann H, Aires-de-Sousa M, Boyce J, Tiemersma E. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 2006;368: 874-85.
44. Martinez-Martinez L, Garcia I, Ballesta S, Benedi VJ, Hernandez-Alles S, Pascual A. Energy-dependent accumulation of fluoroquinolones in quinolone-resistant Klebsiella pneumoniae strains. Antimicrob Agents Chemother 1998; 42(7):1850-2.
45. Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 2003;348(14):1342-7.
46. Walsh C. Molecular mechanisms that confer antibacterial drug resistance. Nature 2000;46:775-81.
47. Tenover FC. Mechanisms of antimicrobial resistance in bacteria. Am J Med 2006;119:S3-10.
48. Vester B, Long K S. Antibiotic resistance in bacteria caused by modified nucleosides in 23S ribosomal RNA. In: Grosjean H, editor. DNA and RNA modification enzymes: structure, mechanism, function and evolution. Austin: Landes Bioscience; 2009.
49. Bush K. Is it important to identify extended-spectrum betalactamase-producing isolates? Eur J Clin Microbiol Infect Dis 1996;15(5):361-4.
50. Wang M, Sahm DF, Jacoby GA, Hooper DC. Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States. Antimicrob Agents Chemother 2004; 48(4):1295-9.
51. Martinez-Martinez L, Pascual A, Garcia I, Tran J, Jacoby GA. Interaction of plasmid and host quinolone resistance. Antimicrob Chemother 2003;51:1037-9.
52. Anderson KL. Is bacterial resistance to antibiotics an appropriate example of evolutionary change? Creat Res Soc Quarterly 2005;41(4):318-26.
53. Speer BS, Shoemaker NB, Salyers AA. Bacterial resistance to tetracycline: mechanisms, transfer, and clinical signifi-cance. Clin Microbiol Rev 1992;5(4):387-99.
54. Siegel RE. Emerging gram-negative antibiotic resistance: daunting challenges declining sensitivities, and dire consequences. Respir Care 2008;53(4):471-9.
55. Schweizer HP. Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related: unanswered questions. Genet Mol Res 2003;2(1):48-62.
56. Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 2002;34:634-40.
57. Bradford PA. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology and detection of this important resistance threat. Clin Microbiol Rev 2001;14:933-51.
58. Cavallo JD, Plesiat P, Coetdic G, Leblanc F, Fabre R. Mechanisms of β-lactam resistance in Pseudomonas aeruginosa: prevalence of OprM-overproducing strains in a Frech multicentre study (1997). J Antimicrob Chemother 2002;50:1039-43.
59. Matsuo Y, Eda S, Gotoh N, Yoshihara E, Nakae T. MexZmediated regulation of mexXY multidrug efflux pump expression in Pseudomonas aeruginosa by binding on the mexZ-mexX intergenic DNA. FEMS Microbiol Lett 2004; 238:23-8.
60. Piddock LJV. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 2006;19(2):382-402.
61. Siderenko SV. Prakticheskoje rukovodstvo po antiinfekcionnoj khimioterapii. (A practical guide to anti-infec tive chemotherapy.) In: Strachunskovo LS, Belousova JB, Kozlova SN, editors. M{cyrillic}oskva; 2002. http://www.microbiology.ru/rus/ar/index.shtml
62. Ferguson D, Cahill OJ, Quilty B. Phenotypic, molecular and antibiotic resistance profiling of nosocomial Pseudomonas aeruginosa strains isolated from two Irish hospitals. J Medicine 2007;1(1):1-14.